FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4317892299> ?p ?o ?g. }

• W4317892299 abstract "Abstract Background PD-1 antibodies have been approved for treating several cancers. However, data regarding the safety and efficacy of these agents in HIV-infected patients with cancers is lacking, because these patients are frequently omitted from clinical trials. Objectives The primary aim of our research is to assess the safety, activity, and long-term outcomes of PD-1 inhibitors in the treatment of HIV-infected patients with advanced cancers. Method We retrospectively analyzed data from HIV-infected patients with advanced cancers who were treated with PD-1 inhibitors at Shanghai Public Health Clinical Center, Shanghai, China. Results Fifteen HIV-infected patients (all are men; yellow race; median age, 44)with cancers who were treated with chemotherapy and/or combined the other oncology treatments (along with combined antiretroviral therapy (cART)) prior to Sintilimab (12 out of 15) or Nivolumab (1 out of 11) or Camrelizumab (2 out of 11) injection were identified. Eight patients responded to treatment (disease control rate 53.3%), with 1 got partial response (PR) and 7 were stable. Most treatment-emergent adverse events (TEAEs) were grade 1 or 2including anemia, leukopenia, hyperglycemia, granulocytopenia, and thrombocytopenia. Eight patients (53.3%) experienced treatment-related AEs (TRAEs) with grades 3/4including myelosuppression, infection, and neurological disorders. CD4 count and HIV RNA remained stable throughout the treatment. Conclusions When used in HIV-infected patients with advanced malignancies, PD-1 inhibitors tend to have favorable efficacy, manageable side effects, and no deteriorated impacts on HIV-RNA and CD4 + T count." @default.
• W4317892299 created "2023-01-25" @default.
• W4317892299 creator A5008576143 @default.
• W4317892299 creator A5020087892 @default.
• W4317892299 creator A5021983179 @default.
• W4317892299 creator A5061553387 @default.
• W4317892299 creator A5063481044 @default.
• W4317892299 creator A5076421973 @default.
• W4317892299 creator A5082333718 @default.
• W4317892299 creator A5082857859 @default.
• W4317892299 date "2023-01-24" @default.
• W4317892299 modified "2023-10-18" @default.
• W4317892299 title "Use of Programmed Cell Death Protein 1 (PD-1) Inhibitor Therapy in HIV-infected Patients with Advanced Cancer:a single-center study from China" @default.
• W4317892299 cites W1893566975 @default.
• W4317892299 cites W1978436252 @default.
• W4317892299 cites W2014116920 @default.
• W4317892299 cites W2019607817 @default.
• W4317892299 cites W2028840312 @default.
• W4317892299 cites W2035852466 @default.
• W4317892299 cites W2087806319 @default.
• W4317892299 cites W2088541970 @default.
• W4317892299 cites W2095081508 @default.
• W4317892299 cites W2096322385 @default.
• W4317892299 cites W2097514222 @default.
• W4317892299 cites W2104347254 @default.
• W4317892299 cites W2110558548 @default.
• W4317892299 cites W2112121482 @default.
• W4317892299 cites W2119896120 @default.
• W4317892299 cites W2124114936 @default.
• W4317892299 cites W2127129197 @default.
• W4317892299 cites W2128035403 @default.
• W4317892299 cites W2131550376 @default.
• W4317892299 cites W2146188586 @default.
• W4317892299 cites W2148422519 @default.
• W4317892299 cites W2151089514 @default.
• W4317892299 cites W2156353875 @default.
• W4317892299 cites W2225639217 @default.
• W4317892299 cites W2292383635 @default.
• W4317892299 cites W2473608950 @default.
• W4317892299 cites W2789343266 @default.
• W4317892299 cites W2800751318 @default.
• W4317892299 cites W2901185593 @default.
• W4317892299 cites W2907362583 @default.
• W4317892299 cites W2911264428 @default.
• W4317892299 cites W2913946693 @default.
• W4317892299 cites W2914803641 @default.
• W4317892299 cites W2946998144 @default.
• W4317892299 cites W2962219096 @default.
• W4317892299 cites W3017737112 @default.
• W4317892299 cites W3133011268 @default.
• W4317892299 cites W3206593389 @default.
• W4317892299 cites W4200083948 @default.
• W4317892299 cites W4210750489 @default.
• W4317892299 cites W4281722052 @default.
• W4317892299 cites W4294379471 @default.
• W4317892299 doi "https://doi.org/10.21203/rs.3.rs-2474777/v1" @default.
• W4317892299 hasPublicationYear "2023" @default.
• W4317892299 type Work @default.
• W4317892299 citedByCount "0" @default.
• W4317892299 crossrefType "posted-content" @default.
• W4317892299 hasAuthorship W4317892299A5008576143 @default.
• W4317892299 hasAuthorship W4317892299A5020087892 @default.
• W4317892299 hasAuthorship W4317892299A5021983179 @default.
• W4317892299 hasAuthorship W4317892299A5061553387 @default.
• W4317892299 hasAuthorship W4317892299A5063481044 @default.
• W4317892299 hasAuthorship W4317892299A5076421973 @default.
• W4317892299 hasAuthorship W4317892299A5082333718 @default.
• W4317892299 hasAuthorship W4317892299A5082857859 @default.
• W4317892299 hasBestOaLocation W43178922991 @default.
• W4317892299 hasConcept C121608353 @default.
• W4317892299 hasConcept C126322002 @default.
• W4317892299 hasConcept C143998085 @default.
• W4317892299 hasConcept C197934379 @default.
• W4317892299 hasConcept C2776694085 @default.
• W4317892299 hasConcept C2777701055 @default.
• W4317892299 hasConcept C2778248108 @default.
• W4317892299 hasConcept C2780030458 @default.
• W4317892299 hasConcept C2780873365 @default.
• W4317892299 hasConcept C535046627 @default.
• W4317892299 hasConcept C71924100 @default.
• W4317892299 hasConcept C90924648 @default.
• W4317892299 hasConceptScore W4317892299C121608353 @default.
• W4317892299 hasConceptScore W4317892299C126322002 @default.
• W4317892299 hasConceptScore W4317892299C143998085 @default.
• W4317892299 hasConceptScore W4317892299C197934379 @default.
• W4317892299 hasConceptScore W4317892299C2776694085 @default.
• W4317892299 hasConceptScore W4317892299C2777701055 @default.
• W4317892299 hasConceptScore W4317892299C2778248108 @default.
• W4317892299 hasConceptScore W4317892299C2780030458 @default.
• W4317892299 hasConceptScore W4317892299C2780873365 @default.
• W4317892299 hasConceptScore W4317892299C535046627 @default.
• W4317892299 hasConceptScore W4317892299C71924100 @default.
• W4317892299 hasConceptScore W4317892299C90924648 @default.
• W4317892299 hasLocation W43178922991 @default.
• W4317892299 hasOpenAccess W4317892299 @default.
• W4317892299 hasPrimaryLocation W43178922991 @default.
• W4317892299 hasRelatedWork W2357273538 @default.
• W4317892299 hasRelatedWork W2361544313 @default.
• W4317892299 hasRelatedWork W2367148332 @default.
• W4317892299 hasRelatedWork W2800160190 @default.

• next